(Q43612836)

25 November 2017

1 reference

title

Gene therapy for malignant gliomas (English)

1 reference

25 November 2017

0 references

Alavi JB

1

1 reference

25 November 2017

Eck SL

series ordinal

2

1 reference

25 November 2017

publication date

1 June 1998

1 reference

Hematology / Oncology Clinics of North America

25 November 2017

published in

1 reference

25 November 2017

volume

12

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

617-629

1 reference

The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Adenovirus-mediated p53 gene delivery inhibits 9L glioma growth in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Immunobiology of gliomas: new perspectives for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Transduction of cytosine deaminase gene makes rat glioma cells highly sensitive to 5-fluorocytosine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Intracavitary liposome-mediated p53 gene transfer into glioblastoma with endogenous wild-type p53 in vivo results in tumor suppression and long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Preferential radiosensitization of 9L glioma cells transduced with HSV-tk gene by acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

The role of adjuvant radiation therapy in the treatment of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Adenovirus-mediated gene transfer to the brain: methodological assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Gene therapy of malignant glioma via inhibition of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Angiogenesis in malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Transfection with bFGF sense and antisense cDNA resulting in modification of malignant glioma growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Intracranial administration of adenovirus expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory response.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970011-3

7 January 2021

10.1016/S0889-8588(05)70011-3

Identifiers

DOI

1 reference

25 November 2017

1 reference